BlinkLab (ASX:BB1) Research & Development: A$0.00 Mil (TTM As of Dec. 2025)


ASX:BB1 BlinkLab Ltd ASX:BB1
16 GF Score
Price A$0.58
! 2 Warning Signs
View Full Analysis

What is BlinkLab Research & Development?

BlinkLab ASX:BB1 -3.33% 16 Research & Development is A$0.00 Mil as of Dec. 2025. GuruFocus rates ASX:BB1 with a GF Score™ of 16/100. The stock has 2 warning signs investors should review.

Research & Development is the aggregate amount of research and development expenses during the year. BlinkLab's Research & Development for the six months ended in Dec. 2025 was A$0.00 Mil. Its Research & Development for the trailing twelve months (TTM) ended in Dec. 2025 was A$0.00 Mil.


BlinkLab  (ASX:BB1) Research & Development Explanation

If competitive advantage is created by a patent or tech advantage, at some point it will disappear.

High R&D usually dictates high SG&A which threatens the competitive advantage.


BlinkLab Research & Development Related Terms


BlinkLab Research & Development Historical Data

* Premium members only.

The historical data trend for BlinkLab's Research & Development can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

BlinkLab Research & Development Chart

BlinkLab Annual Data
Trend Jun23 Jun24 Jun25
Research & Development
0.00 0.18 2.60

BlinkLab Semi-Annual Data
Dec22 Jun23 Jun24 Dec24 Jun25 Dec25
Research & Development Get a 7-Day Free Trial 0.00 0.00 0.00 0.00 0.00
ASX:BB1
16GF Score
BlinkLab Ltd ASX:BB1
Research & Development is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

BlinkLab Research & Development Calculation

This is the expense the company spent on research and development.

Research & Development for the trailing twelve months (TTM) ended in Dec. 2025 adds up the semi-annually data reported by the company within the most recent 12 months, which was A$0.00 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Research & Development →
What does a Research & Development of A$0.00 Mil mean?
BlinkLab (ASX:BB1) has a Research & Development of A$0.00 Mil as of Dec. 2025. Research and development expense is the total cost for research and development activities. View historical data on BlinkLab and its competitors.
Is BlinkLab's Research & Development too high?
BlinkLab's current Research & Development is A$0.00 Mil. Overall, BlinkLab has a GF Score™ of 16/100, reflecting its overall financial health beyond just this single metric.
How does BlinkLab's Research & Development compare to VEEV and BTSG?
BlinkLab's Research & Development of A$0.00 Mil can be compared against companies in the Healthcare Providers & Services industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Research & Development for a Healthcare Providers & Services company?
A good Research & Development depends on the Healthcare Providers & Services industry context. However, Research & Development should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Research & Development mean?
A high Research & Development can signal that a stock is expensive relative to its fundamentals. Research and development expense is the total cost for research and development activities. View historical data on BlinkLab and its competitors. BlinkLab's current Research & Development is A$0.00 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is BlinkLab stock overvalued right now?
BlinkLab (ASX:BB1) has a current Research & Development of A$0.00 Mil. The current Research & Development is A$0.00 Mil. BlinkLab's overall GF Score™ is 16/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Research & Development calculated?
Research & Development is calculated from a company's financial statements. For BlinkLab (ASX:BB1), the current Research & Development is A$0.00 Mil as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

BlinkLab Business Description

Address 216 Street Georges Tce, Level 4, Perth, WA, AUS, 6000
BlinkLab Ltd is a company that has the license to commercialize the Licensed IP and has developed a smartphone-based application with an e-platform that serves as a medical device to perform neurometric tests to aid in the diagnosis of ASD, ADHD, schizophrenia, and other neurodevelopmental conditions. The results from the BlinkLab Tests are recorded by smartphone and uploaded to BlinkLab's confidential and secure online platform where the data is analyzed.
16GF Score

Get the complete analysis for ASX:BB1

Research & Development is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

A$0.58
Price